331 related articles for article (PubMed ID: 33841637)
1. LncRNA RUSC1-AS1 contributes to the progression of hepatocellular carcinoma cells by modulating miR-340-5p/CREB1 axis.
Liu C; Tang L; Xu M; Lin Y; Shen J; Zhou L; Ho L; Lu J; Ai X
Am J Transl Res; 2021; 13(3):1022-1036. PubMed ID: 33841637
[TBL] [Abstract][Full Text] [Related]
2. LncRNA RUSC1-AS1 promotes the proliferation of hepatocellular carcinoma cells through modulating NOTCH signaling.
Chen YA; Cheng L; Zhang Y; Peng L; Yang HG
Neoplasma; 2020 Nov; 67(6):1204-1213. PubMed ID: 32701359
[TBL] [Abstract][Full Text] [Related]
3. LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis.
Ding Y; Huang Y; Zhang F; Gong L; Liang C; Ding K; He X; Ding X; Chen Y
J Transl Med; 2023 Nov; 21(1):854. PubMed ID: 38008726
[TBL] [Abstract][Full Text] [Related]
4. LncRNA RUSC1-AS1 promotes osteosarcoma progression through regulating the miR-340-5p and PI3K/AKT pathway.
Tong CJ; Deng QC; Ou DJ; Long X; Liu H; Huang K
Aging (Albany NY); 2021 May; 13(16):20116-20130. PubMed ID: 34048366
[TBL] [Abstract][Full Text] [Related]
5. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
6. LncRNA DDX11-AS1 accelerates hepatocellular carcinoma progression via the miR-195-5p/MACC1 pathway.
Wan T; Zheng J; Yao R; Yang S; Zheng W; Zhou P
Ann Hepatol; 2021; 20():100258. PubMed ID: 32961346
[TBL] [Abstract][Full Text] [Related]
7. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis.
Huang C; Li K; Huang R; Zhu J; Yang J
Life Sci; 2021 Feb; 267():118928. PubMed ID: 33358902
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
9. LncRNA CDKN2B-AS1 Promotes Cell Viability, Migration, and Invasion of Hepatocellular Carcinoma via Sponging miR-424-5p.
Shen X; Li Y; He F; Kong J
Cancer Manag Res; 2020; 12():6807-6819. PubMed ID: 32801906
[TBL] [Abstract][Full Text] [Related]
10. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
Dong H; Jian P; Yu M; Wang L
J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA ZEB2-AS1 Promotes Hepatocellular Carcinoma Progression by Regulating The
Wu SM; Chen J; Liang Y; Luo Q; Tong YY; Xie L
Cell J; 2022 Jun; 24(6):285-293. PubMed ID: 35892230
[TBL] [Abstract][Full Text] [Related]
12. LncRNA GAS6-AS2 facilitates tumor growth and metastasis of hepatocellular carcinoma by activating the PI3K/AKT/FoxO3a signaling pathway.
Liang C; Pang L; Ke Y; Ji W; Xiong J; Ding R; Ding Y
Int J Clin Exp Pathol; 2019; 12(11):4011-4023. PubMed ID: 31933797
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
14. LncRNA loc339803 acts as CeRNA of miR-30a-5p to promote the migration and invasion of hepatocellular carcinoma cells.
Xue C; Zhang X; Gao P; Cui X; Zhu C; Qin X
J Cancer; 2021; 12(4):1061-1072. PubMed ID: 33442404
[No Abstract] [Full Text] [Related]
15. The lncRNA ZEB2-AS1 is upregulated in gastric cancer and affects cell proliferation and invasion via miR-143-5p/HIF-1α axis.
Wu F; Gao H; Liu K; Gao B; Ren H; Li Z; Liu F
Onco Targets Ther; 2019; 12():657-667. PubMed ID: 30705594
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA TRIM52-AS1 Promotes Growth and Metastasis via miR-218-5p/ROBO1 in Hepatocellular Carcinoma.
Liu Y; Wu Y; Liu S; Dai Y
Cancer Manag Res; 2021; 13():547-558. PubMed ID: 33519234
[TBL] [Abstract][Full Text] [Related]
17. RUSC1-AS1 promotes the malignant progression of breast cancer depending on the regulation of the miR-326/XRCC5 pathway.
Ayoufu A; Paierhati P; Qiao L; Zhang N; Abudukeremu M
Thorac Cancer; 2023 Aug; 14(24):2504-2514. PubMed ID: 37429610
[TBL] [Abstract][Full Text] [Related]
18. Long-non-coding RNA RUSC1-AS1 accelerates osteosarcoma development by miR-101-3p-mediated Notch1 signalling pathway.
Jiang R; Zhang Z; Zhong Z; Zhang C
J Bone Oncol; 2021 Oct; 30():100382. PubMed ID: 34367901
[TBL] [Abstract][Full Text] [Related]
19. RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis.
Fen H; Hongmin Z; Wei W; Chao Y; Yang Y; Bei L; Zhihua S
Curr Pharm Des; 2020; 25(43):4630-4640. PubMed ID: 31692433
[TBL] [Abstract][Full Text] [Related]
20. LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis.
Bi H; Shang Z; Jia C; Wu J; Cui B; Wang Q; Ou T
Onco Targets Ther; 2020; 13():11277-11288. PubMed ID: 33177836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
